Abstract
The occurrence and behavior of carbamazepine (CBZ) was investigated in aquatic environment of Yangtze River Delta, East China. The water samples were enriched by solid-phase extraction and analyzed by high-performance liquid chromatography with diode array detector. The validation of the analytical method included linearity (0.1–1 mg/L), recovery studies, and determination of limits of quantification. Limits of quantification of CBZ in various aquatic samples were in the range of 0.1–0.2 μg/L. CBZ was detected in the Tongji University Intramural River, the Huangpu River, and the Suzhou River with the highest concentration of 1,090 ng/L, but not detected in the Nanhengyin River and the Caojia River. In sewage water samples, CBZ was not detected in one of the sewage treatment plants (STPs) but was detected in the raw influents and effluents at the other three selected STPs in Shanghai, with the concentrations ranging from 230 to 1,110 ng/L. CBZ was not completely eliminated after secondary treatment (with the active sludge process).
Similar content being viewed by others
References
Andreozzi, R., Marotta, R., Pinto, G., & Pollio, A. (2002). Carbamazepine in water: Persistence in the environment, ozonation treatment and preliminary assessment on algal toxicity. Water Research, 36(11), 2869–2877.
Benotti, M. J., & Brownawell, B. J. (2007). Distributions of pharmaceuticals in an urban estuary during both dry- and wet-weather conditions. Environmental Science and Technology, 41(26), 5795–5802.
Brian, J. V., Harris, C. A., Scholze, M., Kortenkamp, A., Booy, P., Lamoree, M., et al. (2007). Evidence of estrogenic mixture effects on the reproductive performance of fish. Environmental Science and Technology, 41(1), 337–334.
Castiglioni, S., Bagnati, R., Fanelli, R., Pomati, F., Calamar, D., & Zuccato, E. (2006). Removal of pharmaceuticals in sewage treatment plants in Italy. Environmental Science and Technology, 40(1), 357–363.
Clara, M., Strenn, B., Ausserleitner, M., & Kreuzinger, N. (2004a). Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant. Water Science and Technology, 50(5), 29–36.
Clara, M., Strenn, B., & Kreuzinger, N. (2004b). Carbamazepine as a possible anthropogenic marker in the aquatic environment: Investigations on the behavior of carbamazepine in wastewater treatment and during groundwater infiltration. Water Research, 38(4), 947–954.
Ferrari, B., Paxeus, N., Giudice, R. L., Pollio, A., & Garric, J. (2003). Ecotoxicological impact of pharmaceuticals found in treated wastewaters: Study of carbamazepine, clofibric acid and diclofenac. Ecotoxicology and Environmental Safety, 55(3), 359–370.
Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W., & Gilman, A. G. (1996). The pharmacological basis of therapeutics. New York: McGraw-Hill.
Heberer, T. (2002a). Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data. Toxicology Letters, 131(1–2), 5–17.
Heberer, T. (2002b). Tracking persistent pharmaceutical residues from municipal sewage to drinking water. Journal of Hydrology, 266(3–4), 175–189.
Heberer, T., Verstraeten, I. M., Meyer, M. T., Mechlinski, A., & Reddersen, K. (2001). Occurrence and fate of pharmaceuticals during bank filtration—Preliminary results from investigations in Germany and the United States. Water Resources Update, 120, 4–17.
Jones, O. A. H., Voulvoulis, N., & Lester, J. N. (2002). Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Research, 36(20), 5013–5022.
Joss, A., Keller, E., Alder, A. C., Gobel, A., McArdell, C. S., & Ternes, T. (2005). Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Research, 39(14), 3139–3152.
Kim, S. D., Cho, J., Kim, I. S., Vanderford, B. J., & Snyder, S. A. (2007). Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Research, 41(5), 1013–1021.
Maggs, J. L., Pirmohamed, M., Kitteringham, N. R., & Park, B. K. (1997). Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography/mass spectrometry. Drug Metabolism and Disposition, 25(3), 275–280.
Miao, X. S., & Metcalfe, C. D. (2003a). Determination of carbamazepine and its metabolites in aqueous samples using liquid chromatography–electrospray tandem mass spectrometry. Analytical Chemistry, 75(15), 3731–3738.
Miao, X. S., & Metcalfe, C. D. (2003b). Determination of cholesterol-lowering statin drugs in aqueous samples using liquid chromatography–electrospray ionization tandem mass spectrometry. Journal of Chromatography A, 998(1–2), 133–141.
Miao, X. S., Yang, J. J., Metcalfe, C. D. (2005). Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environmental Science and Technology, 39(19), 7469–7475.
Moldovan, Z. (2006). Occurrences of pharmaceutical and personal care products as micropollutants in rivers from Romania. Chemosphere, 64(11), 1808–1817.
Nakada, N., Tanishima, T., Shinohara, H., Kiri, K., & Takada, H. (2006). Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Research, 40(17), 3297–3303.
Nakada, N., Komori, K., Suzuki, Y., Konishi, C., Houwa, I., & Tanaka, H. (2007). Occurrence of 70 pharmaceutical and personal care products in Tone River basin in Japan. Water Science and Technology, 56(12), 133–140.
Oaks, J. L., Gilbert, M., Virani, M. Z., Watson, R. T., Meteyer, C. U., & Rideout, B. A. (2004). Diclofenac residues as the cause of vulture population decline in Pakistan. Nature, 427(6975), 630–633.
Palmer, P. M., Wilson, L. R., O’ Keefe, P., Sheridan, R., King, T., & Chen, C. Y. (2008). Sources of pharmaceutical pollution in the New York City Watershed. Science of the Total Environment, 394(1), 90–102.
Paxéus, N. (2004). Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Science and Technology, 50(5), 253–260.
Rabiet, M., Togola, A., Brissaud, F., Seidel, J. L., Budzinski, H., & Elbaz-Poulichet, F. (2006). Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized mediterranean catchment. Environmental Science and Technology, 40(17), 5282–5288.
Radjenovic, J., Petrovic, M., & Barceló, D. (2007). Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Analytical and Bioanalytical Chemistry, 387(4), 1365–1377.
Skadsen, J. M., Rice, B. L., & Meyering, D. J. (2004). The occurrence and fate of pharmaceuticals, personal care products and endocrine disrupting compounds in a municipal water use cycle: A case study in the city of Ann Arbor. City of Ann Arbor, Water Utilities and Fleis & VandenBrink Engineering, Inc., available at http://www.a2gov.org/government/publicservices/water_treatment/Documents/EndocrineDisruptors.pdf.
Snyder, S. A., Westerhoff, P., Yoon, Y., & Sedlak, D. L. (2003). Pharmaceuticals, personal care products, and endocrine disruptors in water: Implications for the water industry Pharmaceuticals, personal care products, and endocrine disruptors in water: Implications for the water industry. Environmental Engineering Science, 20(5), 449–469.
Sosiak, A., & Hebben, T. A. (2005). Preliminary survey of pharmaceuticals and endocrine disrupting compounds in treated municipal wastewaters and receiving rivers of Alberta. Alberta Environ, available at http://environment.gov.ab.ca/info/library/7604.pdf.
Spongberg, A. L., & Witter, J. D. (2008). Pharmaceutical compounds in the wastewater process stream in Northwest Ohio. Science of the Total Environment, 397(1–3), 148–157.
Suntisukaseam, U., Weschayanwiwat, P., & Sabatini, D. A. (2007). Sorption of amphiphile pharmaceutical compounds onto polar and nonpolar adsorbents. Environmental Engineering Science, 24(10), 1457–1465.
Ternes, T. A. (1998). Occurrence of drugs in German sewage treatment plants and rivers. Water Research, 32(11), 3245–3260.
Ternes, T. A. (2001). Occurrence of pharmaceuticals in surface waters (Vorkommen von Pharmaka in Gewässern). Wasser und Boden, 53(4), 9–14.
Ternes, T. A., Kreckel, P., & Mueller, J. (1999). Behaviour and occurrence of estrogens in municipal sewage treatment plants—II. Aerobic batch experiments with activated sludge. Science of the Total Environment, 225(1–2), 91–99.
Ternes, T., Bonerz, M., & Schmidt, T. (2001). Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography–electrospray tandem mass spectrometry. Journal of Chromatography A, 938(1–2), 175–185.
Ternes, T. A., Meisenheimer, M., McDowell, D., Sacher, F., Brauch, H. J., Haist-Gulde, B., et al. (2002). Removal of pharmaceuticals during drinking water treatment. Environmental Science and Technology, 36(17), 3855–3863.
Ternes, T. A., Herrmann, N., Bonerz, M., Knacker, T., Siegrist, H., & Joss, A. (2004). A rapid method to measure the solid–water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge. Water Research, 38(19), 4075–4084.
Thacker, P. D. (2005). Pharmaceutical data elude environmental researchers. Environmental Science and Technology, 39(9), 193A–194A.
Vieno, N., Tuhkanen, T., Kronberg, L. (2007). Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Research, 41(5), 1001–1012.
Wiegel, S., Aulinger, A., Brockmeyer, R., Harms, H., Löffler, J., Reincke, H., et al. (2004a). Pharmaceuticals in the river Elbe and its tributaries. Chemosphere, 57(2), 107–126.
Weigel, S., Kallenborn, R., & Hühnerfuss, H. (2004b). Simultaneous solid phase extraction of acidic, neutral and basic pharmaceuticals from aqueous samples at ambient (neutral) pH and their determination by GC–MS. Journal of Chromatography A, 1023(2), 183–195.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhou, X.F., Dai, C.M., Zhang, Y.L. et al. A preliminary study on the occurrence and behavior of carbamazepine (CBZ) in aquatic environment of Yangtze River Delta, China. Environ Monit Assess 173, 45–53 (2011). https://doi.org/10.1007/s10661-010-1369-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10661-010-1369-8